P36897 (TGFR1_HUMAN) Homo sapiens (Human)
TGF-beta receptor type-1 UniProtKBInterProSTRINGInteractive Modelling
It is possible new templates exist for this target since these models were created.
Available Structures
40 Experimental Structures
Description | PDB ID | Oligo-state | Range | Ligands | ||
---|---|---|---|---|---|---|
CRYSTAL STRUCTURE OF THE CYTOPLASMIC DOMAIN OF THE TYPE I TGF-BETA RECEPTOR IN COMPLEX WITH FKBP12 |
Heteromer P62942; | 1×SO4; | ||||
Assess | ||||||
Ternary structure of GDF11 bound to ActRIIB-ECD and Alk5-ECD |
Heteromer O95390; P38445; | 4×NAG; | ||||
Assess | ||||||
Structural basis for cooperative assembly of the TGF-beta signaling complex |
Heteromer P10600; P37173; | |||||
Assess | ||||||
Ternary complex of TGF-b1 reveals isoform-specific ligand recognition and receptor recruitment in t… |
Heteromer P01137; P37173; | |||||
Assess | ||||||
CYTOPLASMIC DOMAIN OF UNPHOSPHORYLATED TYPE I TGF-BETA RECEPTOR CRYSTALLIZED WITHOUT FKBP12 | homo-5-mer | 15×SO4; | ||||
Assess | ||||||
Crystal structure of TGFbRI complexed with a pyrazolone inhibitor | monomer | 1×JZO; 3×PO4; | ||||
Assess | ||||||
Crystal structure of TGFbRI complexed with a 2-aminoimidazole inhibitor | monomer | 1×55F; 3×PO4; | ||||
Assess | ||||||
Crystal structure of TGFbRI complexed with an indolinone inhibitor | monomer | 1×ZOP; | ||||
Assess | ||||||
TGF-BETA RECEPTOR TYPE 1 KINASE DOMAIN (T204D,I211V,Y249F,S280T, Y282F,S287N,A350C,L352F) IN COMPLE… | monomer | 1×STU; 1×GOL; | ||||
Assess | ||||||
TGF-BETA RECEPTOR TYPE 1 KINASE DOMAIN (T204D) IN COMPLEX WITH N-(3-fluoropyridin-4-yl)-2-[6-(trifl… | monomer | 1×D0A; | ||||
Assess | ||||||
TGF-BETA RECEPTOR TYPE 1 KINASE DOMAIN (T204D) IN COMPLEX WITH 6-[4-(3-CHLORO-4-FLUOROPHENYL)-1-(2-… | monomer | 1×QMV; 1×GOL; | ||||
Assess | ||||||
Crystal Structure of a Naphthyridine Inhibitor of Human TGF-beta Type I Receptor | monomer | 1×460; | ||||
Assess | ||||||
TGF-BETA RECEPTOR TYPE 1 KINASE DOMAIN (T204D,I211V,Y249F,S280T, Y282F,S287N,A350C,L352F) | monomer | 3×GOL; | ||||
Assess | ||||||
The Crystal Structure of Tgf-Beta Type I Receptor (Alk5) from Biortus | monomer | 1×A1D6I; 2×EDO; 2×ACT; | ||||
Assess | ||||||
Selection of fragments for kinase inhibitor design: decoration is key | monomer | 1×3WJ; 1×SO4; | ||||
Assess | ||||||
Selection of fragments for kinase inhibitor design: decoration is key | monomer | 1×3WK; 1×SO4; 1×TRS; | ||||
Assess | ||||||
Selection of fragments for kinase inhibitor design: decoration is key | monomer | 1×3WA; 1×SO4; | ||||
Assess | ||||||
Selection of fragments for kinase inhibitor design: decoration is key | monomer | 1×3WN; 1×SO4; | ||||
Assess | ||||||
Selection of fragments for kinase inhibitor design: decoration is key | monomer | 1×3WO; 1×SO4; | ||||
Assess | ||||||
TGF-BETA RECEPTOR TYPE 1 KINASE DOMAIN (T204D) IN COMPLEX WITH N-{4-[3-(5-METHOXYPYRIDIN-2-YL)-1H-P… | monomer | 1×J2Y; 1×GOL; | ||||
Assess | ||||||
Selection of fragments for kinase inhibitor design: decoration is key | monomer | 1×SO4; | ||||
Assess | ||||||
TGF-BETA RECEPTOR TYPE 1 KINASE DOMAIN (T204D) IN COMPLEX WITH STAUROSPORINE | monomer | 1×STU; 2×GOL; | ||||
Assess | ||||||
ALK5 IN COMPLEX WITH 4-((5,6-dimethyl-2-(2-pyridyl)-3-pyridyl)oxy)-N-(3,4,5-trimethoxyphenyl)pyridi… | monomer | 1×ZZG; 1×EDO; | ||||
Assess | ||||||
Crystal Structure of TGF-beta receptor I kinase with inhibitor | monomer | 1×SO4; 1×PY1; | ||||
Assess | ||||||
Crystal Structure of TGF-beta receptor I kinase with ATP site inhibitor | monomer | 1×580; | ||||
Assess | ||||||
TGF-BETA RECEPTOR TYPE 1 KINASE DOMAIN (T204D) IN COMPLEX WITH 3-AMINO-6-[4-(2-HYDROXYETHYL)PHENYL]… | monomer | 1×5L4; | ||||
Assess | ||||||
TGF-BETA RECEPTOR TYPE 1 KINASE DOMAIN (T204D) IN COMPLEX WITH N-{4-[3-(6-fluoropyridin-3-yl)-4-oxo… | monomer | 1×J2M; 2×GOL; | ||||
Assess | ||||||
TGF-BETA RECEPTOR TYPE 1 KINASE DOMAIN (T204D) | monomer | 3×GOL; | ||||
Assess | ||||||
TGF-BETA RECEPTOR TYPE 1 KINASE DOMAIN (T204D) IN COMPLEX WITH 6-[1-(2,2-DIFLUOROETHYL)-4-(6-METHYL… | monomer | 1×QMY; 3×GOL; | ||||
Assess | ||||||
TGF-BETA RECEPTOR TYPE 1 KINASE DOMAIN (T204D) IN COMPLEX WITH N-{4-[3-(6-METHOXYPYRIDIN-3-YL)-1H-P… | monomer | 1×J2V; | ||||
Assess | ||||||
TGF-BETA RECEPTOR TYPE 1 KINASE DOMAIN (T204D,I211V,Y249F, S280T,Y282F,S287N,A350C,L352F) IN COMPLE… | monomer | 1×5L4; | ||||
Assess | ||||||
TGF-BETA RECEPTOR TYPE 1 KINASE DOMAIN (WT) | monomer | |||||
Assess | ||||||
ALK5 in complex witha an N-(4-anilino-2-pyridyl)acetamide inhibitor. | monomer | 2×EDO; 1×ZUQ; | ||||
Assess | ||||||
ALK-5 kinase inhibitor complex | monomer | 1×8LY; | ||||
Assess | ||||||
The Crystal Structure of the Type I TGF beta receptor from Biortus. | monomer | 1×A1D6I; | ||||
Assess | ||||||
Structure of Alk5 + GW855857 | monomer | 1×855; | ||||
Assess | ||||||
ALK-5 kinase complex with GW857175 | monomer | 1×QIG; | ||||
Assess | ||||||
TGF-beta Receptor type 1 in complex with SB431542 | monomer | 1×085; | ||||
Assess | ||||||
ALK5 IN COMPLEX WITH 4-((4-((2,6-dimethyl-3-pyridyl)oxy)-2-pyridyl) amino)benzenesulfonamide | monomer | 1×EDO; 1×ZZF; | ||||
Assess | ||||||
Solution structure of the extracellular domain of the TGF-beta type I receptor | monomer | |||||
Assess |
1 SWISS-MODEL model
Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
---|---|---|---|---|---|---|
1ias.1.A | homo-5-mer | 0.80 | 100.00 | |||
Assess |
3 SWISS-MODEL models built on isoform sequence
Template | Isoform | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) |
---|---|---|---|---|---|---|
Isoform 2 | 1ias.1.A | homo-5-mer | 0.80 | 100.00 | ||
Assess | ||||||
Isoform 3 | 1b6c.3.B | monomer | 0.82 | 99.68 | ||
Assess | ||||||
Isoform 3 | 3pyy.1.A | monomer | 0.50 | 27.76 | ||
Assess |